These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9234298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunoradiometric assay for prolactin in serum and tissue--comparison with radioimmunoassay.
    Ohnami S, Nakata H, Eto S.
    Radioisotopes; 1990 Sep; 39(9):393-5. PubMed ID: 2236664
    [Abstract] [Full Text] [Related]

  • 4. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
    Arosio M, Nissim M, Ballabio M, Orefice R, Bazzoni N, Faglia G.
    Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
    [Abstract] [Full Text] [Related]

  • 5. Effects of anti-prolactin autoantibodies on serum prolactin measurements.
    Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H.
    Eur J Endocrinol; 1994 May; 130(5):434-7. PubMed ID: 8180668
    [Abstract] [Full Text] [Related]

  • 6. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP, Berke B, Cohen LA.
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [Abstract] [Full Text] [Related]

  • 7. Serum prolactin in uraemia: correlations between bioactivity and activity in two immunoassays.
    Smith CR, Butler J, Iggo N, Norman MR.
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):295-300. PubMed ID: 2929235
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
    Cavaco B, Prazeres S, Santos MA, Sobrinho LG, Leite V.
    J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
    [Abstract] [Full Text] [Related]

  • 10. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F.
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [Abstract] [Full Text] [Related]

  • 11. Comparison of RIA kits with polyclonal antiserum and IRMA kits with monoclonal antibodies for the determination of plasma prolactin and somatotropin in patients with pituitary adenoma.
    Oosterom R, Lamberts SW.
    J Clin Chem Clin Biochem; 1985 Jan; 23(1):51-4. PubMed ID: 3981090
    [Abstract] [Full Text] [Related]

  • 12. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
    Cavaco B, Leite V, Santos MA, Arranhado E, Sobrinho LG.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2342-6. PubMed ID: 7629227
    [Abstract] [Full Text] [Related]

  • 13. Development of a two-site immunoradiometric assay for dimeric inhibin using antibodies against chemically synthesized fragments of the alpha and beta subunit.
    Knight PG, Groome N, Beard AJ.
    J Endocrinol; 1991 May; 129(2):R9-12. PubMed ID: 2040852
    [Abstract] [Full Text] [Related]

  • 14. Macroprolactinaemia associated with prolactin adenoma.
    Mounier C, Trouillas J, Claustrat B, Duthel R, Estour B.
    Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
    [Abstract] [Full Text] [Related]

  • 15. Molecular size variants of prolactin and growth hormone in mouse serum: strain differences and alterations of concentrations by physiological and pharmacological stimuli.
    Sinha YN.
    Endocrinology; 1980 Dec; 107(6):1959-69. PubMed ID: 7428700
    [Abstract] [Full Text] [Related]

  • 16. The production and characterisation of monoclonal antibodies against human prolactin and the development of a two-site immunoradiometric assay.
    Baines MG, Rafferty B, Patel V, Ferguson K, Jeffcoate SL, Thorpe R.
    J Immunoassay; 1989 Dec; 10(1):75-91. PubMed ID: 2715347
    [Abstract] [Full Text] [Related]

  • 17. Measurement of dimeric inhibin using a modified two-site immunoradiometric assay specific for oxidized (Met O) inhibin.
    Knight PG, Muttukrishna S.
    J Endocrinol; 1994 Jun; 141(3):417-25. PubMed ID: 8071641
    [Abstract] [Full Text] [Related]

  • 18. Advantages of IRMA over RIA in the measurement of ACTH.
    Gibson S, Pollock A, Littley M, Shalet S, White A.
    Ann Clin Biochem; 1989 Nov; 26 ( Pt 6)():500-7. PubMed ID: 2559649
    [Abstract] [Full Text] [Related]

  • 19. Polymers of prolactin and their clinical significance.
    Fraser IS, Zhuang GL.
    Obstet Gynecol Surv; 1990 Aug; 45(8):515-20. PubMed ID: 2198504
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibodies against human, bovine and rat prolactin: epitope mapping of human prolactin and development of a two-site immunoradiometric assay.
    Staindl B, Berger P, Kofler R, Wick G.
    J Endocrinol; 1987 Aug; 114(2):311-8. PubMed ID: 2443594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.